At ObesityWeek 2024, researchers presented the latest data on treatment regimens for chronic weight management, including GLP ...

Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor.

Treatment with apremilast proved safe and effective over a 48-week period for the management of early oligoarticular psoriatic arthritis. Apremilast (APR) shows significant efficacy and safety ...

After peak in 2020, significant decrease seen in firearm injury-related visit rates year over year from 2020 to 2023. HealthDay News — Firearm injury-related emergency department visit rates ...

Seasonal maternal RSV vaccination may be cost-effective, particularly for those with higher risks. HealthDay News — Seasonal maternal respiratory syncytial virus (RSV) vaccination and nirsevimab ...

Each single-dose Zurnai autoinjector delivers a dose of 1.5mg nalmefene (base) in 0.5mL. The Food and Drug Administration (FDA) has approved Zurnai ™, the first nalmefene HCl autoinjector for ...

Credit: Getty Images The American Academy of Sleep Medicine published guidance regarding the treatment of restless leg syndrome and periodic limb movement disorder. The American Academy of Sleep ...

Researchers evaluated the efficacy and safety of ixekizumab over a 16-week period for the treatment of juvenile psoriatic arthritis or enthesitis-related arthritis.